Delivery Order SPE2DB25D3109-SPE2DB25FP4NY
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,375.76. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $4,303.88 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 5, 2025, with completion targeted for June 6, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which was competitively awarded with no set-aside designation, is effective through August 11, 2025, and utilizes firm fixed pricing. AmerisourceBergen will perform fulfillment from its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed price contract type. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside contract represents a competitively awarded transaction for medical supplies supporting federal healthcare procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,250.55 for Dexcom G7 sensors, with an ultimate completion date of September 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FP4NYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,071.44 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of September 18, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger indefinite delivery contract (IDC) vehicle, representing a routine procurement of continuous glucose monitoring devices for military healthcare support. The contract was awarded to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location and primary place of performance. This delivery order is issued under AmerisourceBergen's substantial $999.999 billion prime IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains extensive capabilities to supply military and veteran healthcare systems with a broad range of pharmaceutical products and medical devices. The Dexcom G7 sensors represent a specialized medical supply within the company's larger portfolio supporting Defense Health Agency operations and other government healthcare systems worldwide.